Research correspondence

DOI: 10.4244/EIJ-D-22-00090

A study of the novel SinoCrown system for transcatheter aortic valve implantation

Qingrong Liu1,2, PhD; Ju Mei2,3, MD; Hongliang Zhang1, MD; Wenbing Zhou2, MBBS; Kejin Qiu4, MD; Qing Zhou2, MS; Yang Chen1, MD; Wei Duan2, MBBS; Changping Zhou2, MS; Min Tang3, MD; Jianbing Huang3, MD; Haixia Liu2, MBBS; Qingqing Liu2, MBBS; Rencao Chang4, MS; Guannan Niu1, MD; Yuxin Zhang4, MS; Tao Wu4, MS; Ting Zhang4, MS; Weiyi Fang2, MD; Yongjian Wu1,2, MD; Runlin Gao1, MD

Transcatheter aortic valve implantation (TAVI) has become a mainstay in treatment for severe symptomatic aortic stenosis (AS) patients1. Over the past decades, various transcatheter devices have been invented and tested for safety and efficacy2. This manuscript aims to report a novel device and initial experience with the SinoCrown system (Lepu Medical Technology Co., Ltd).

SinoCrown has numerous unique design features that distinguish it from other self-expanding valves. It is made up of a self-expanding nitinol stent and three valve leaflets which are made of bovine pericardial tissue (Figure 1). It was designed with a short stent that could reduce the risk of coronary obstruction. The pre-bend designed for the delivery system increases flexibility and controllability during propulsion. For transfemoral delivery, flexible delivery catheters are available in three sizes (18, 19 and 21 Fr). For transapical delivery, a 27 Fr flexible delivery catheter is included. A new version of the catheter is being developed for release which will have a smaller delivery system. The delivery system has a stable and reliable locking/unlocking structure that ensures the unlocking of...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Volume 18 Number 17
Apr 24, 2023
Volume 18 Number 17
View full issue

Key metrics

On the same subject

10.4244/EIJV11SWA33 Sep 17, 2015
Transfemoral TAVI devices: design overview and clinical outcomes
Abdel-Wahab M et al


10.4244/EIJ-D-16-00103 Jun 2, 2017
A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team
Amrane H et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al


10.4244/EIJV11I6A136 Oct 20, 2015
New Braile Inovare transcatheter aortic prosthesis: clinical results and follow-up
Gaia D et al

Expert review

10.4244/EIJ-D-19-00788 Nov 15, 2019
Residual challenges in TAVI: moving forward
Barbanti M et al
Trending articles


10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al


10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al

State of the art

10.4244/EIJ-D-22-00969 Jun 19, 2023
Functional coronary angiography for the assessment of the epicardial vessels and the microcirculation
Faria D et al

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved